跳至主要内容
临床试验/NCT06506773
NCT06506773已完成不适用

A Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis Less Than 12 Months of Age

Vertex Pharmaceuticals Incorporated50 个研究点 分布在 11 个国家目标入组 79 人开始时间: 2024年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
79
试验地点
50
主要终点
Proportion of Participants with FE-1 greater than or equal to (≥) 200 microgram per gram (µg/g) Over Time

研究概览

简要总结

The purpose of the study is to evaluate the natural history of exocrine pancreatic function by assessing Fecal elastase-1 (FE-1) in infants with CF during their first year of life.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Participants with CF less than (<) 6 months of age at the index date
  • Participants not eligible to receive commercial Kalydeco™ (based on local product labels) and are not receiving Kalydeco or any other cystic fibrosis transmembrane conductance regulator gene (CFTR) modulator

排除标准

  • Participant whose mother took any CFTR modulator while pregnant with the participant, or who has any history of exposure to a CFTR modulator
  • Other protocol defined Inclusion/Exclusion criteria apply.

结局指标

主要结局

Proportion of Participants with FE-1 greater than or equal to (≥) 200 microgram per gram (µg/g) Over Time

时间窗: From Enrollment up to the Infant turning 12 Months of Age

次要结局

  • FE-1 level Over Time(From Enrollment up to the Infant turning 12 Months of Age)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (50)

Loading locations...

相似试验

Natural History Study of Exocrine Pancreatic... | 临床试验